Prostate cancer incidence varies greatly worldwide, with higher rates in Europe and North America, especially in Western and Northern regions. Although the incidence in Asian countries is lower, it has been increasing in recent years. Advances in screening and diagnostic technologies have also influenced detection rates.
1. Silent progression easily overlooked
In its early stages, prostate cancer may have no obvious symptoms, only manifesting as difficulty urinating or increased nighttime urination, which is easily mistaken for benign prostatic hyperplasia, delaying treatment opportunities.
2. Bone metastasis causing severe pain
Cancer cells can quickly metastasize through the bloodstream to bones, especially the spine and pelvis, causing persistent bone pain, impairing mobility, and reducing quality of life.
3. Urinary system dysfunction
Tumor compression of the urethra leads to urinary obstruction and retention. In advanced stages, catheterization may be required to maintain urination, seriously affecting self-care ability.
4. Psychological burden
As a male-specific cancer, prostate cancer impacts reproductive health and male dignity. Patients often experience anxiety and depression, which affect recovery.
Immune reconstruction cell therapy reinfuses activated immune cells to stimulate the immune system, enabling it to actively recognize and eliminate cancer cells. This therapy can be combined with conventional radiotherapy or surgery to enhance long-term tumor control, particularly suitable for individuals at high risk of recurrence and metastasis, providing a novel solution to delay disease progression.
During actual treatment, cancer patients undergoing surgery, radiotherapy, and chemotherapy often face immune dysfunction, increased risk of infection, and slow recovery. To better support patients during treatment, improve tolerance, and enhance survival quality, phased immune reconstruction plans should be scientifically designed for different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to boost the effectiveness of anti-tumor treatment.
● Mid-term plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term plan: Enhance overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby improving quality of life and prolonging survival.
1. Surgical treatment
Radical prostatectomy is suitable for localized cases, completely removing cancerous tissue and reducing recurrence risk. With technological advancements, minimally invasive laparoscopic and robot-assisted surgeries are widely used, reducing trauma and recovery time.
2. Radiation therapy
Radiation therapy includes external beam radiation and brachytherapy. It is suitable for patients not eligible for surgery or as adjuvant therapy post-surgery. It precisely targets tumors while maximizing protection of healthy tissues.
3. Hormone therapy
By inhibiting androgen production or blocking its receptor, the hormonal environment required for cancer cell growth is reduced. This is commonly used in advanced or metastatic patients.
4. Minimally invasive methods
Techniques such as microwave ablation and radiofrequency ablation can control tumors to some extent, with minimal trauma and fast recovery, suitable for some early-stage or inoperable patients.
5. Cryoablation
For early localized lesions, probes are inserted through the perineum into the tumor target. Argon gas is injected to rapidly freeze the lesion below –40°C, forming an ice ball that destroys cancer cells. This preserves normal gland tissue, reducing the risk of incontinence and sexual dysfunction, but requires precise imaging guidance.
As a common male malignancy, prostate cancer seriously threatens health and quality of life. Scientific diagnosis and treatment are essential. Immune reconstruction cell therapy brings new therapeutic approaches. Experts at United Life International Medical Center emphasize that combining multiple treatments with early intervention can significantly improve outcomes.